Article info
Cognitive neurology
Research paper
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
- Correspondence to Dr Jin-Tai Yu, Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, Shandong 266071, China; yu-jintai{at}163.com
Citation
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
Publication history
- Received January 16, 2014
- Revised April 24, 2014
- Accepted April 25, 2014
- First published May 14, 2014.
Online issue publication
November 15, 2016
Article Versions
- Previous version (15 November 2016).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions